Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation.

Venue / Journal

Vaccine

Date

Mon, 02/24/2020 - 12:00

Additional Journal Information

38(9):2229-2240

Authors

Angelidou A, Conti MG, Diray-Arce J, Benn CS, Shann F, Netea MG, Liu M, Potluri LP, Sanchez-Schmitz G, Husson R, Ozonoff A, Kampmann B, van Haren SD, Levy O.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/32005538